Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Deviation Handling in Aerosol Production

Posted on By

SOP for Deviation Handling in Aerosol Production

Standard Operating Procedure for Deviation Handling in Aerosol Production

1) Purpose

The purpose of this SOP is to establish procedures for identifying, documenting, investigating, and resolving deviations from established processes or specifications during aerosol production. Effective deviation handling ensures product quality, regulatory compliance, and continuous process improvement.

2) Scope

This SOP applies to all deviations encountered during aerosol production processes at [Company Name], including deviations related to equipment, materials, personnel, and environmental conditions.

3) Responsibilities

Quality Assurance (QA) Manager: Oversee deviation handling procedures and ensure timely resolution.
Production Supervisor: Notify QA of deviations and collaborate on investigation and corrective actions.
Operators: Report deviations promptly and assist in providing accurate information for investigation.
Quality Control (QC): Verify the impact of deviations on product quality and compliance.

See also  SOP for Equipment Qualification in Aerosol Production

4) Procedure

4.1 Deviation Identification:
4.1.1 Operators or supervisors identify and document deviations from standard procedures, specifications, or expectations.
4.1.2 Record initial observations, including date, time, location, and description of the deviation.

4.2 Notification:
4.2.1 Immediately notify QA and relevant personnel upon discovery of a deviation.
4.2.2 Use designated forms or electronic systems to document and communicate deviation details.

4.3 Initial Assessment:
4.3.1 QA conducts a preliminary assessment to determine the severity and potential impact of the deviation.
4.3.2

Classify deviations based on risk assessment criteria (e.g., critical, major, minor).

4.4 Investigation:
4.4.1 Establish an investigation team, including representatives from QA, production, and other relevant departments.
4.4.2 Conduct a thorough root cause analysis to identify the underlying cause(s) of the deviation.
4.4.3 Document investigation findings, including contributing factors and corrective actions.

See also  SOP for Validation of Cleaning Procedures in Aerosol Production

4.5 Corrective and Preventive Actions (CAPA):
4.5.1 Develop and implement appropriate corrective actions to address the root cause of the deviation and prevent recurrence.
4.5.2 Determine effectiveness of corrective actions through verification and follow-up.
4.5.3 Implement preventive actions to mitigate potential future deviations based on lessons learned.

4.6 Documentation:
4.6.1 Maintain detailed records of all deviation reports, investigations, and CAPA activities.
4.6.2 Archive documentation in a controlled manner for traceability and regulatory inspections.
4.6.3 Review and update SOPs based on findings from deviation investigations and CAPA implementation.

5) Abbreviations, if any

SOP: Standard Operating Procedure
QA: Quality Assurance
QC: Quality Control
CAPA: Corrective and Preventive Actions

See also  SOP for Annual Product Review in Aerosol Production

6) Documents, if any

Deviation Report Form
Investigation Report
CAPA Plan and Verification Records
SOP for Deviation Handling

7) Reference, if any

ICH Q9: Quality Risk Management
FDA Guidance for Industry: Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production
ISO 9001: Quality management systems – Requirements

8) SOP Version

Version 1.0

Aerosols Tags:Aerosol batch manufacturing, Aerosol change control procedures, Aerosol cleaning validation, Aerosol contamination prevention, Aerosol documentation requirements, Aerosol equipment calibration, Aerosol equipment cleaning, Aerosol final product inspection, Aerosol formulation development, Aerosol in-process testing, Aerosol manufacturing process, Aerosol method development, Aerosol microbial testing, Aerosol packaging guidelines, Aerosol particle size analysis, Aerosol personnel training, Aerosol process validation, Aerosol production SOP, Aerosol quality control, Aerosol raw material inspection, Aerosol stability testing, Aerosol stability testing methods, Aerosol sterility maintenance, Aerosol storage conditions, Aerosol waste disposal procedures

Post navigation

Previous Post: SOP for Analytical Method Development Elemental Impurity Testing
Next Post: SOP for Maintenance of Weighing and Dispensing Equipment

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version